Perceptive Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $481,783 - $994,224	-14,326 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $454,134 - $1 Million	14,326 New	14,326 $892,000
Q1 2018 May 15, 2018	SELL	$20.04 - $29.71 $2.05 Million - $3.05 Million	-102,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $1.81 Million - $1.95 Million	102,500	102,500 $1.95 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.